Angina

Clinical Trial Finder

Many patients with angina are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

The Effect of Remote Ischemic Preconditioning on Major Organ Function in Patients With Coronary Artery Disease Undergoing Orthopedic Surgery

Conditions:   Angina Pectoris;   Myocardial Infarction
Interventions:   Procedure: Remote ischemic preconditioning;   Procedure: Sham control
Sponsor:   Seoul National University Hospital
Not yet recruiting - verified June 2016

Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris

Conditions:   Coronary Stenosis;   Angina Pectoris
Intervention:   Radiation: Computed tomographic angiography of coronary artery
Sponsor:   Guiyang No.4 People's Hospital
Not yet recruiting - verified June 2016

Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   Bassett Healthcare;   Baylor University
Not yet recruiting - verified June 2016

ALDOsterone for Prediction of Post-Operative Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   University Hospital, Caen
Recruiting - verified June 2016

Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients

Conditions:   Coronary Artery Disease;   Stable Angina;   Unstable Angina
Interventions:   Other: Computed Tomography Angiography;   Other: Intra-operative graft flow rate measurement
Sponsor:   National Heart Centre Singapore
Active, not recruiting - verified May 2016

Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions

Condition:   Percutaneous Transluminal Coronary Angioplasty
Intervention:   Other: 5 year Follow-up
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Not yet recruiting - verified June 2016

Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients

Condition:   Radiation Pneumonitis
Intervention:   Drug: Nicorandil
Sponsor:   Taipei Medical University WanFang Hospital
Enrolling by invitation - verified June 2016

Smartphone Delivered In-home Cardiopulmonary Rehabilitation

Conditions:   Cardiovascular Disease;   Coronary Artery Disease
Interventions:   Behavioral: MULTIFIT Cardiac Rehabilitation;   Behavioral: Movn Pulmonary Rehabilitation;   Behavioral: Standard of Care Cardiac Rehabilitation
Sponsor:   Emory University
Recruiting - verified May 2016

Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings

Condition:   Heart Failure
Intervention:   Device: Cardiogoniometry
Sponsor:   Hull and East Yorkshire Hospitals NHS Trust
Recruiting - verified February 2016

Prehabilitation to Improve Functional and Clinical Outcomes in Patients With Aortic Stenosis

Condition:   Aortic Stenosis
Interventions:   Other: Prehabilitation;   Other: Usual Care
Sponsor:   Mayo Clinic
Recruiting - verified May 2016

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Acetylsalicylic acid;   Drug: Rivaroxaban;   Drug: Clopidogrel;   Drug: Ticagrelor
Sponsors:   Janssen Research & Development, LLC;   Bayer;   Duke Clinical Research Institute;   Harvard Medical School
Recruiting - verified June 2016

Multicenter Study to Develop a Risk Model for Early Major Cardiovascular Events

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   Instituto Mexicano del Seguro Social
Recruiting - verified June 2016

Diuretic Comparison Project

Condition:   Hypertension
Interventions:   Drug: Hydrochlorothiazide;   Drug: Chlorthalidone
Sponsor:   VA Office of Research and Development
Recruiting - verified June 2016

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified June 2016

Asan Multivessel Registry

Condition:   Coronary Artery Disease
Intervention:   Other: Treatment
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Recruiting - verified June 2016

Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Ertugliflozin;   Drug: Placebo
Sponsors:   Merck Sharp & Dohme Corp.;   Pfizer
Recruiting - verified June 2016

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified June 2016

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Placebo;   Drug: Linagliptin
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified June 2016

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Condition:   Stable Coronary Artery Disease (CAD), Myocardial Infarction
Intervention:  
Sponsor:   AstraZeneca
Active, not recruiting - verified June 2016

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Condition:   Coronary Artery Disease (CAD)
Interventions:   Drug: Ticagrelor;   Drug: Acetylsalicylic Acid;   Drug: Clopidogrel
Sponsors:   ECRI bv;   Biosensors International;   AstraZeneca;   The Medicines Company
Active, not recruiting - verified April 2016

Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG

Conditions:   Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo - Ticagrelor;   Drug: Placebo - Aspirin
Sponsors:   Deutsches Herzzentrum Muenchen;   AstraZeneca
Recruiting - verified June 2016

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Conditions:   Diabetes Mellitus, Non-Insulin-Dependent;   High Risk for Cardiovascular Event
Interventions:   Drug: Dapagliflozin 10 mg;   Drug: Placebo tablet
Sponsors:   AstraZeneca;   Bristol-Myers Squibb;   The TIMI Study Group;   Hadassah Medical Organization
Active, not recruiting - verified June 2016

A Study of Evacetrapib in High-Risk Vascular Disease

Condition:   Cardiovascular Diseases
Interventions:   Drug: Evacetrapib;   Drug: Placebo
Sponsors:   Eli Lilly and Company;   The Cleveland Clinic
Active, not recruiting - verified June 2016

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Condition:   Acute Coronary Syndrome
Interventions:   Drug: alirocumab;   Drug: Placebo
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified June 2016

"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy

Condition:   Stroke
Interventions:   Biological: rfVIIa;   Other: Standard saline solution
Sponsors:   Dr. David Gladstone;   Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2016

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: linagliptin;   Drug: glimepiride;   Drug: linagliptin placebo;   Drug: glimepride placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting - verified June 2016

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

Condition:   Coronary Artery Disease
Interventions:   Procedure: Cypher, xience, Endeavor, Taxus;   Drug: optimal medical therapy
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Recruiting - verified June 2016